|
A cross-sectional study on prevalence of self-medication practice among the students of University of Dhaka
|
|
| Author:
|
NAZMUS SAQUEEB, MD.MIJANUR RAHMAN, ASHFIA TASNIM MUNIA, S.M.ABDUR RAHMAN, MD.ABDUL MUHIT, K.M.YASIF KAYES SIKDAR
|
| Abstract:
|
Self-medication is the use of medicine by the patients for self-recognized symptoms without consulting with licensed clinicians. This practice is potentially associated with antibiotic resistance, morbidity and mortality due to toxic side-effects. To identify the prevalence of self- medication among the students of University of Dhaka, a questionnaire-based survey was conducted from August 08, 2017 to December 14, 2017 and analyzed statistically. A total of 805 students of different disciplines of both sex (Male; 638, 79.3%, Female; 167, 20.7%) were participated. According to the survey, common diseases were more prevalent among male students (79.3%) than in female (20.7%). Moreover, prevalence of common diseases among the students is significant (p<0.05) on the basis of sex but insignificant (p>0.05) in age group. On the other hand, higher degree holders (15.53%) practiced less self-medication than the bachelor degree holders (34.41%). The drug groups which were most commonly self-medicated were analgesics (39.5%), antibiotics (36.9%), and antihistamines (24.0%). Moreover, association between sex and side effects after self-medication were significant with p-value <0.05 where association between age group of the students and side effects after self-medication were not significant with p-value >0.05. Besides, results revealed that the principal reason behind self-medication is not to have enough time to consult with a doctor (47.82%) while others pointed out about the inability to manage appointment with physicians (16.4%). As the study showed that self-medication practice among the students of University of Dhaka is very alarming, so awareness should be raised among the students to overcome the scenario.
|
| Keyword:
|
Self-medication, prevalence, common diseases, therapeutic drug groups.
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2021.13.02.316
|
| Download:
|
Request For Article
|
|
|